CD8A and infection: OTS LAV-candidates provided protection against lethal SARS-CoV-2 challenge infection, inducing neutralizing antibody responses (Extended Data Fig. 4k) and SARS-CoV-2 spike-specific CD8+ T cell responses (Extended Data Fig. 4l).